Now Reading: Lupin Q1 Sales Surge 33% to Rs 8,217 Crore
-
01
Lupin Q1 Sales Surge 33% to Rs 8,217 Crore
Lupin reported a 33.3% year-on-year sales jump to Rs 8,217 crore for the first quarter of FY27, Business Today reports. EBITDA rose 42.8% to Rs 2,580 crore, while profit after tax increased…
The Story in Brief
Lupin reported a 33.3% year-on-year sales jump to Rs 8,217 crore for the first quarter of FY27, Business Today reports. EBITDA rose 42.8% to Rs 2,580 crore, while profit after tax increased 16% to Rs 1,417 crore. The company attributed the performance to robust growth across the US, India, and other markets, along with improved profitability. Executive director Ramesh Swaminathan highlighted the product pipeline and R&D investments as key drivers.
The Indian Opinion
The Lupin numbers are strong, but the narrative of a pharma revival needs tempering. Sales growth is driven by one-off US launches and a low base. Many analysts already warn that US price erosion and R&D spend could squeeze margins in coming quarters. The real test will be whether Lupin can sustain double-digit growth without new blockbuster approvals. Watch next quarter's US sales mix.
Source: businesstoday.in
This story was synthesised by AI from the source linked above.
